Scinovex
articleTop 1% cited

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Kidney International · 1995 · Vol. 47(1) · pp. 186–192
Robert N. FoleyPatrick S. ParfreyJohn D. HarnettGloria M. KentChristopher J. MartinDavid C. MurrayPaul E. Barré
Dialysis and Renal Disease ManagementCardiovascular Function and Risk FactorsCardiac pacing and defibrillation studiesMedicineInternal medicineCardiologyCoronary artery diseaseLeft ventricular hypertrophyEnd stage renal diseaseHeart failureDialysisAnginaHemodialysis

MeSH terms

Coronary DiseaseEchocardiographyFemaleRenal DialysisHumansKidney Failure, ChronicMaleMiddle AgedPrognosisProspective StudiesCohort StudiesPrevalenceSurvival AnalysisVentricular Function, Left
Citations
1,294
FWCI
17.63
field-weighted impact
References
39
Percentile
100%
vs. same field & year
Citations per year
References
Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
The American Journal of Cardiology · 1987 · 807 citations
Canadian Hemodialysis Morbidity Study
American Journal of Kidney Diseases · 1992 · 544 citations
A Survey of Vascular Access for Haemodialysis in The Netherlands
Nephrology Dialysis Transplantation · 1991 · 462 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy · Scinovex